aap Implantate AG

M&A Activity • Oct 25, 2005

News Details

Ad-hoc | 25 October 2005 12:34

aap Implantate AG: Two Acquisitions in the Biomaterials Segment

Ad hoc announcement §15 WpHG Mergers & Acquisitions aap Implantate AG: Two Acquisitions in the Biomaterials Segment Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— aap Implantate AG: Two Acquisitions in the Biomaterials Segment aap Implantate AG, a German medical technology company specialized in healing bone fractures, joint replacement, bone cements and biomaterials, is acquiring retroactively from July 1, 2005, all of the shares in Osartis GmbH & Co. KG (previously holding 49%) and a 51% stake in ADC Advanced Dental Care GmbH & Co. KG, both headquartered in Obernburg, Germany, and is thereby extending its activities in the biomaterials segment. The acquisition of ADC is still formally subject to approval by ADC’s shareholder meeting. Osartis develops and manufactures the synthetic bone replacement material Ostim that aap already distributes in Germany and Austria. Osartis markets Ostim in various countries via distribution partners. Along with Ostim Osartis is developing a number of other synthetic bone replacement and infection treatment products. ADC distributes on an OEM basis products developed by Osartis in the dental sector. In 2005 the two companies will jointly total around EUR 850,000 in sales. They are consolidated and have already reached breakeven at the net profit level. aap is paying for the acquisition by issuing around 350,000 shares in aap Implantate AG and repaying around EUR 500,000 in loan capital. Osartis and ADC are to be integrated into the biomaterials division that aap plans to set up at the beginning of 2006. aap is currently engaged in negotiations with other potential partners in Europe and Asia on international distribution of Ostim and plans at the same time to apply in the months ahead to the FDA for Ostim approval in the United States. aap Implantate AG Lorenzweg 5 12099 Berlin Deutschland ISIN: DE0005066609 WKN: 506660 Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart End of ad hoc announcement (c)DGAP 25.10.2005 251234 Okt 05